[301]
2008 Occupational Cancer
[254,6 KB]
From [www.racp.edu.au] Last viewed: 07.09.2006
Occupational Cancer
A guide to prevention, assessment and investigation
AFOM Working Party on Occupational Cancer
The Australasian Faculty of Occupational Medicine
May 2003
Page 2
2
CONTENTS
PREFACE .4
EXECUTIVE SUMMARY . .5
1. INTRODUCTION .8
The role of physical and chemical agents in cancer causation .8
How carcinogens are identified .8
Classification of carcinogens .9
How many cancers are work related? . .10
Practical implications .11
2. PRIMARY PREVENTION OF OCCUPATIONAL CANCER . .13
Elimination of carcinogenic exposures .13
Minimising the exposure .14
Worker induction and training . .15
Workplace monitoring . .15
Pre-placement screening of high risk individuals . .16
Genetic screening . .16
Management of workers with past exposure .17
3. SURVEILLANCE OF WORKERS EXPOSED TO CARCINOGENS ...
[302]
PREGNANCY AND BREAST CANCER Guideline No. 12
[153,7 KB]
From [www.rcog.org.uk] Last viewed: 07.09.2006
PREGNANCY AND BREAST CANCER
1.
Introduction
Breast cancer remains the most common cancer in women,with a lifetime risk of almost 11% (one in nine)
in the UK.
1
There has been an overall increase in the incidence of breast cancer but in the UK mortality has
fallen by over 30% in the last decade.It is likely that this is due to the widespread introduction of tamoxifen
in treatment regimens and the introduction of breast screening.
2
Obstetricians will see an increasing number of women who are pregnant or seeking pregnancy after
treatment for breast cancer .This guideline updates the RCOG advice published in July 1997.
2.
Methodology
A literature search was performed using Medline (1997–2002).The key words used were ‘breast cancer ’,
‘breast neoplasms’,‘mastectomy’,‘pregnancy’,‘pregnancy complications’,‘breastfeeding’,‘lactation’,‘fertility’,
‘inf...
[303]
Cancer 2004 draft 11-08-04
[424,8 KB]
From [www.dchd.net] Last viewed: 07.09.2006
November 2004
Cancer : The National
Challenge*
Center for Health Statistics Report
Volume 3, Issue 4
Cancer
Cancer : The National Challenge
1
Cancer Health Disparities at the
Local Level
1
Jacksonville Cancer Report Card
2
Healthy Jacksonville Cancer Coalition
3
Tomorrow’s Rainbow
Breast and Cervical Cancer Program
4
Healthy Men Prostate Cancer
Awareness Program
5
Screenings to Prevent Cancer Deaths
6
* From Healthy People 2010, U.S. Department of
Health and Human Services
This issue:
percent of the chance of someone not
diagnosed with cancer . Five-year
relative survival rates commonly are
used to monitor progress in the early
detection and treatment of cancer and
include persons who are living 5
...
[304]
Cancer Care Ontario Practice Guidelines Initiative
[131,9 KB]
From [www.cancercare.on.ca] Last viewed: 07.09.2006
Chemotherapy in Stage IV (Metastatic) Non-Small Cell Lung Cancer
Practice Guideline Report #7-2
ORIGINAL GUIDELINE: February 14, 1996
MOST RECENT LITERATURE SEARCH: January, 2003
NEW EVIDENCE ADDED TO THE GUIDELINE REPORT: January, 2002
RECOMMENDATIONS MODIFIED: January, 2002
INFORMATION UPDATE: January, 2005
A new practice guideline encompassing the role of first-line chemotherapy in the treatment of
advanced and metastatic non-small cell lung cancer is under development by the Lung Cancer
Disease Site Group. When completed (estimated completion in 2005), the new practice
guideline report (PG#7-10 The role of first-line chemotherapy in the treatment of advanced non-
small cell lung cancer ) will replace the practice guidelines listed below. These guidelines will no
longer be updated on the Cancer Care Ontario Web site.
PG#7-2, Chemotherapy in stage IV (metastatic non-small ...
[305]
Cancer Care Ontario Practice Guidelines Initiative
[866,8 KB]
From [www.cancercare.on.ca] Last viewed: 07.09.2006
Chemotherapy in Stage IV (Metastatic) Non-Small Cell Lung Cancer
Practice Guideline Report #7-2
ORIGINAL GUIDELINE: February 14, 1996
MOST RECENT LITERATURE SEARCH: January, 2003
NEW EVIDENCE ADDED TO THE GUIDELINE REPORT: January, 2002
RECOMMENDATIONS MODIFIED: January, 2002
INFORMATION UPDATE: January, 2005
A new practice guideline encompassing the role of first-line chemotherapy in the treatment of
advanced and metastatic non-small cell lung cancer is under development by the Lung Cancer
Disease Site Group. When completed (estimated completion in 2005), the new practice
guideline report (PG#7-10 The role of first-line chemotherapy in the treatment of advanced non-
small cell lung cancer ) will replace the practice guidelines listed below. These guidelines will no
longer be updated on the Cancer Care Ontario Web site.
PG#7-2, Chemotherapy in stage IV (metastatic non-small ...
[306]
Palliative surgery in the treatment of cancer patients
[551,5 KB]
From [www.kunnskapssenteret.no] Last viewed: 07.09.2006
Palliative surgery in the treatment
of cancer patients
Report no. 8/2003
Norwegian centre for Health Technology Assessment
Page 2
SINTEF REPORT
TITLE
Palliative surgery in the treatment of cancer patients
AUTHOR(S)
Karl-Erik Giercksky, Jon Erik Grønbech, Tor Hammelbo, Henry
Hirschberg, Tryggve Lundar, Odd Mjåland, Lodve Stangeland, Jon Arne
Søreide, Clement Trovik, Anders Walløe, Rolf Wahlqvist, Nicolai Wessel,
Lise Lund Håheim
CLIENTS(S)
SINTEF Unimed
Address::
P.O Box 124, Blindern
0314 Oslo
Location: Forskningsveien 1
Telephone:
22 06 73 00
Fax:
22 06 79 09
Enterprise No.: NO 948 007 029 MVA
Ministry of Health
REPORT NO.
CLASSIFICATION
CLIENTS REF.
SFT78A3408
Open
GRADATION
ISBN
PROJECT NO
NO OF PAGES ...
[307]
Cancer Immunity, Vol. 4, p. 14 (25 November 2004)
[840,2 KB]
From [www.cancerimmunity.org] Last viewed: 07.09.2006
Cancer Immunity, Vol. 4, p. 14 (25 November 2004)
Submitted: 5 August 2004. Accepted: 11 October 2004.
Communicated by: H zur Hausen
www.cancerimmunity.org
1 of 10
Article
About 15% of all human colorectal, gastric, and endometrial tumors ,
and the majority of tumors in patients suffering from hereditary
nonpolyposis colorectal cancer syndrome, are caused by loss of
DNA mismatch repair functions. In the affected cancer cells, this
results in insertion or deletion mutations at short, repetitive DNA
sequences referred to as microsatellites. Such mutations in coding
microsatellites (cMS) cause translational frameshifts that may
destroy gene function. These frameshift mutations could also cause
the translation of immunogenic neopeptides at the carboxy terminus.
Several such mutations have been identified recently. However, since
none of the frameshift-induced ...
[308]
Cancer Care Ontario Practice Guidelines Initiative (16 pt bold)
[1121,4 KB]
From [www.cancercare.on.ca] Last viewed: 07.09.2006
Adjuvant Care for Stage I Ovarian Cancer
Practice Guideline Report #4-13
L. Elit, A. Fyles, A. Chambers, M. Fung Kee Fung, A. Covens, M. Carey, and members of the
Gynecology Cancer Disease Site Group.
Report Date: May 3, 2004
SUMMARY
Guideline Questions
1. What is the role of adjuvant care in women with completely surgically staged stage I ovarian
cancer ?
2. What is the role of adjuvant care in women who receive incomplete or no surgical staging of
ovarian cancer ?
3. What is the optimal strategy for adjuvant care in women with ovarian cancer ?
Target Population
These recommendations apply to women with newly diagnosed stage I ovarian cancer .
Recommendations
• The stage of ovarian cancer is an important prognostic factor that influences survival and
the choice of therapy. The quality of the surgical staging is a key determinant of
treatment ...
[309]
Cancer incidence and mortality in the industrial city of Sumgayit ...
[45,5 KB]
From [www.webstracts.com] Last viewed: 07.09.2006
Cancer incidence and mortality in the industrial city of Sumgayit, Azerbaijan
Andruchow J, Soskolne CL, University of Alberta
Racioppi F, World Health Organization, Rome Division
Makhmudov E, Asadov A, Environmental Rehabilitation of Sumgayit
Senthilselvan A, Cherry NM, University of Alberta
Bryant H, Alberta Cancer Board
Background : The city of Sumgayit, Azerbaijan, was founded in 1949, a centrepiece of
Soviet industrial production. During peak production, more than 40 factories were
actively producing a diverse array of industrial products, including synthetic rubber,
chlorine, aluminium and detergents. The primary goal of Soviet central planners was
maximizing low-cost production, which came at the expense of environmental and
occupational health and safety. Consequently, factory workers and residents of the city
were exposed to a combination of high-level occupational and environmental pollution ...
[310]
What is breast cancer? Breast cancer facts How common is it?
[317,1 KB]
From [info.cancerresearchuk.org] Last viewed: 07.09.2006
breast
cancer
spot the changes early
and why screening is important
What is breast cancer ?
The breast is made up of millions of cells. Breast
cancer develops when a single cell begins to multiply
out of control and forms a tumour. Some cells may
break away and travel to other parts of the body
starting new tumours.
The breast consists of fatty tissue and lobules that
are connected to the nipple by ducts. Breast cancer
usually starts in a cell lining a duct or lobule.
Breast cancer facts
fatty connective tissue
duct
lobules
duct cells
lobular cells
lobule
ducts
More women survive breast cancer today
thanks to earlier detection and better
treatments. But it is a common disease
and the number of cases is rising.
This leaflet contains information about
risk factors for breast cancer and ...
[311]
Cancers Booklet
[405,2 KB]
From [www.pauktuutit.ca] Last viewed: 07.09.2006
scoµZ6 g[ox B o o k T w o
ßm0Jtq5b wo6fy6hD1•3izk5
˜8ix3Nco3is?4g5 Gv8?iC6bsJ6H:
ßm0Jt5 wo6fy6hD1•3izk5
˜8ix3Nco6bwom0JtQJ1N6b4v
Cancers : Actions I Can Take to Reduce
My Risks of Developing Cancer
x3Nw5 wkw5 ˜8ix6ys6toEi3j5 ttC6ymJoxq5
Inuit Women’s Health Series
Page 2
ßm0Jtq5b wo6fy6hD1•3izk5
˜8ix3Nco3is?4g5 Gv8?iC6bsJ6H:
ßm0Jt5 wo6fy6hD1•3izk5
˜8ix3Nco6bwom0JtQJ1N6b4v
wobE/s0Jt5
Xs4©t4f5 d/8NDmK5
grjx4t5yps2lt4 vtmpC˜aJi4
bm4fkz WoExaJk5
grjx4t5ypsMs3iq8k5 x7ml
kNosJi ˜8ix6ys6toEi3j9l
cspQx6tsJi4 scsy4nE/u1i4
scoµZC˜oxaymJk5
giyymc5bMs3iq8k5.
@))@at9lA x3Nw5 wkw5
vg0pctŒQ/q5 vNbu
ttC6t: xlr ÎBx{
wk4t©oEp5: nwt Bws9, Aw8
sh6v6, Bws9b Mws9
˜6r4hwp5: ÷i5 mfÇ{, vhE8 rxE
ttCs/6t: ˜3l6g6 xwWo
scoµZC˜i4 ˜6r4hwp5: ß3{lx
gnsmc5bstoEp5 tuz5
?2fx scoµZC˜oxaJ5
...
[312]
Amâlet Anniat: Piusigisokka Anajanginitsauniagama Sakititsigiamut ...
[215,8 KB]
From [www.pauktuutit.ca] Last viewed: 07.09.2006
A t u a g a K T u g l i K B o o k T w o
Amâlet Anniat: Piusigisokka
Anajanginitsauniagama Sakititsigiamut
Amalimmik Anniamik
Cancers : Actions I Can Take to Reduce
My Risks of Developing Cancer
Inuit Annangita Inosikatsianimmut Atuagangit
Inuit Women’s Health Series
Page 2
Amâlet Anniat: Piusigisokka
Anajanginitsauniagama
Sakititsigiamut Amalimmik Anniamik
KaujijaukKujait
Pauktuutikkut nakummegumajut Pigia-
sijaummat katimattiulauttunik sakKitit-
silaummata malittausonik omunga sulia-
mut ammalu nunakKatiget ânniasiutingi-
nnulu KimiKuKattatungit sakKittitsilaum-
mata Kanuk pivallialimmangâta pijagetta-
uKâtinnagit tamakkua atuagangit.
© 2002 Pauktuutit Inuit
AnnauKatigengita katutjiKatigenningit
Canada-mi
Allati: Aluki Rojas
Inuttotitsijingit: Sadie Hill,
Gwen Ohokak, Hilda Lyall
AkKisuijingit: ...
[313]
Management of head and neck cancers
[618,1 KB]
From [www.york.ac.uk] Last viewed: 07.09.2006
Management of head
and neck cancers
Bulletin on the effectiveness
of health service interventions
for decision makers
Bulletin on the effectiveness
of health service interventions
for decision makers
CENTRE FOR REVIEWS AND DISSEMINATION
VOLUME 8 NUMBER 5 2004 ISSN: 0965-0288
¦ Over the next few years,
assessment and treatment
services for patients with head
and neck cancers will become
increasingly concentrated in
cancer centres serving
populations of over a million.
¦ Multidisciplinary teams
(MDTs) will be central to the
service, each managing at least
100 new cases of upper
aerodigestive tract cancer per
annum. They will be
responsible for assessment,
treatment planning and
management of every patient.
Specialised teams will deal
with patients with thyroid
cancer , and ...
[314]
Head & Neck cancer CSG REP
[406,3 KB]
From [www.nice.org.uk] Last viewed: 07.09.2006
R O Y A L C O L L E G E O F N U R S I N G
RCN guidance for oncology
and haematology nurses
Managing the fertility
of male cancer patients
Page 2
Page 3
Managing the fertility
of male cancer patients
RCN guidance for oncology and haematology nurses
Contents
Introduction
1
Providing information
1
Counselling
1
Consent issues
2
HFEA consent form (96) 6
2
Developing a comprehensive information service
3
Recommendations for the referring unit
3
References and further reading
5
Glossary of terms
6
Appendix 1:Referral form
7
Acknowledgements
Royal College of Nursing Cancer Nurses Forum
Royal College of Nursing Fertility Nurse Group
© 2004 Royal College of Nursing.All rights reserved.No part of this publication may be ...
[315]
Cancer Facts for Women
[79,3 KB]
From [www.cancer.org] Last viewed: 07.09.2006
Breast Cancer
Facts & Figures 2001-2002
Page 2
Table of Contents
What is breast cancer ?
1
Who gets breast cancer ?
1
How has the occurrence of breast cancer changed over time?
3
What factors influence breast cancer survival?
5
What are the known risk factors for breast cancer ?
7
Can breast cancer be prevented?
9
How can breast cancer be detected early?
10
How is breast cancer treated?
11
What research is currently being done on breast cancer ?
14
What resources are available in your community?
15
What is the American Cancer Society doing about breast cancer ?
16
Sources of Statistics
17
References
18
Acknowledgments
The production of this report would not have been possible without the
efforts of: Cheryll Cardinez, MSPH, Vilma Cokkinides, PhD, ...
[316]
Cancer Facts for Men
[183,3 KB]
From [www.cancer.org] Last viewed: 07.09.2006
ARTICLE
Delivering cervical cancer prevention services in
low-resource settings
J. Bradley
a,
T , M. Barone
a
, C. Mahé
b
, R. Lewis
c
, S. Luciani
d
a
EngenderHealth, 440 Ninth Avenue, New York, NY 10001, USA
b
International Agency for Research on Cancer (IARC), Lyon, France
c
JHPIEGO, Baltimore, MD, USA
d
Pan American Health Organization (PAHO), Washington, DC, USA
Abstract
The goals of any cervical cancer prevention program should be threefold:
to achieve high coverage of the population at risk, to screen women with an accurate
test as part of high-quality services, and to ensure that women with positive test
results are properly managed. This article focuses on the experiences of the Alliance
for Cervical Cancer Prevention ...
[317]
The Scientific Basis Behind Alternative Cancer Treatments by Tanya ...
[93,7 KB]
From [www.outsmartyourcancer.com] Last viewed: 07.09.2006
The Scientific Basis Behind Alternative
Cancer Treatments
by Tanya Harter Pierce, MA, MFCC
This is the second article in a 3-part series on alternative cancer treatments. As
mentioned in part 1, a common misconception about alternative approaches to cancer is
that they are not based on sound medical science. The truth is, however, there are several
well-established scientific principles which many alternative cancer treatments are based
on, and these have been successfully demonstrated in scientific tests. This article outlines
two of the most important principles: the trophoblast principle and the anaerobic cell
principle.
The Trophoblast Principle of Cancer
In 1902, Scottish embryologist, Dr. John Beard, observed that cancer cells are virtually
indistinguishable from pre-embryonic cells known as “trophoblasts”. Within the first 5
days after fertilization, human embryonic cells differentiate ...
[318]
Cancer Care Ontario Practice Guidelines Initiative
[687,6 KB]
From [www.cancercare.on.ca] Last viewed: 07.09.2006
The Role of Amifostine as a Radioprotectant in the Management of
Patients with Squamous Cell Head and Neck Cancer
Practice Guideline Report # 5-8
D.I. Hodson, G.P. Browman, K. Thephamongkhol, T. Oliver, L. Zuraw, and members of the
Head and Neck Cancer Disease Site Group
ORIGINAL GUIDELINE: May 13, 2003
NEW EVIDENCE ADDED TO THE GUIDELINE REPORT: November 18 2003
MOST RECENT LITERATURE SEARCH: March 2004
New evidence found by update searches since the completion of the original guideline is
consistent with the original recommendation.
SUMMARY
Guideline Question
For patients with squamous cell head and neck cancer , does amifostine safely and effectively
ameliorate important side effects of radiotherapy with acceptable toxicity and no tumour
protection? Xerostomia, mucositis, and the anti-tumour effects of amifostine were the main
outcomes of interest.
Target ...
[319]
Managing the fertility of male cancer patients: RCN guidance for ...
[862,4 KB]
From [www.rcn.org.uk] Last viewed: 07.09.2006
R O Y A L C O L L E G E O F N U R S I N G
RCN guidance for oncology
and haematology nurses
Managing the fertility
of male cancer patients
Page 2
Page 3
Managing the fertility
of male cancer patients
RCN guidance for oncology and haematology nurses
Contents
Introduction
1
Providing information
1
Counselling
1
Consent issues
2
HFEA consent form (96) 6
2
Developing a comprehensive information service
3
Recommendations for the referring unit
3
References and further reading
5
Glossary of terms
6
Appendix 1:Referral form
7
Acknowledgements
Royal College of Nursing Cancer Nurses Forum
Royal College of Nursing Fertility Nurse Group
© 2004 Royal College of Nursing.All rights reserved.No part of this publication may be ...
[320]
Cancer
[1070,6 KB]
From [www.laskerfoundation.org] Last viewed: 07.09.2006
The Cost of Cancer :
:: On average, each person who dies from cancer loses an estimated
15 years of life. Collectively, more than 8 million years of life were
lost in 1998 because of cancer .
:: The cost of cancer in 2000 is estimated at more than $180 billion:
$60 billion for direct medical costs; $120 billion for low produc-
tivity and premature death.
SOURCE: NATIONAL INSTITUTES OF HEALTH: CANCER PROGRESS REPORT
{HTTP://PROGRESSREPORT. CANCER .GOV}
FACTS:
The Reality:
:: Cancer is the second leading cause of death in the United States.
:: Since 1990, there have been more than 16 million new diagnoses
of cancer in the United States.
:: In 2002, more than 1,500 people a day are expected to die
from cancer .
:: More than 75 percent of all cancers are diagnosed at ages
55 and older.
:: In the United ...
[321]
10/2 prostate cancer risks
[118,6 KB]
From [www.aghealth.org] Last viewed: 07.09.2006
Agricultural Health Study
2003
Prostate Cancer and
Agricultural Pesticides
Iowa Office:
The University of Iowa
100 Oakdale Campus
Iowa City, IA 52242-5000
Collaborating Partners:
Iowa State University Extension
Iowa Department of Agriculture
and Land Stewardship
1-800-217-1954
www.aghealth.org
Risk of prostate cancer increases with frequent use of methyl bromide.
The Agricultural
Health Study
seeks to identify
factors that
promote
good health.
rostate cancer is the most common
cancer (other than nonmelanoma
skin cancer ) in Iowa men. Despite
its common occurrence, we know
little about its causes. The most
consistent risk factors reported are age,
family history, African-American ethnicity,
and hormonal factors. Farming has been the
most consistent occupational ...
[322]
Certification for Cancer Registrars
[65,4 KB]
From [www.ctrexam.org] Last viewed: 07.09.2006
How to Apply
for the CTR Exam
The CTR examination is administered
during two 2-week testing periods in March
and September on a daily basis at over 700
computer-based testing facilities worldwide.
The Candidates Handbook for the CTR
Examination may be requested from the
following sources:
I
Professional Testing Corporation (PTC)
1350 Broadway, 17th Floor
New York, NY 10018
Telephone (212) 356-0660
PTC’s Web site:
http://www.ptcny.com/clients/NCRA
I
National Cancer Registrars Association
Council on Certification
1340 Braddock Place Suite 203
Alexandria, VA 22314
Telephone: (703) 299-6640
fax: (703) 299-6620
Email: ctrexam@ncra-usa.org
I
NCRA Council on Certification’s
Web Site: http://www.ctrexam.org
NCRA is a non-profit, professional organization with
nearly 4,000 members representing the ...
[323]
Cancer Facts_V
[451,5 KB]
From [www.cancer.org] Last viewed: 07.09.2006
H?i Ung Th‹ Mœ l‡ m?t t8 chŸc sŸc kh’e
tø nguyån to‡n qu”c døa v‡o c?ng «“ng,
c” g°ng hy diåt ung th‹, m?t vvn «ä sŸc
kh’e quan trÜng, b¢ng c·ch ngÊn ngÿa
ung th‹, cŸu sanh mÂng, v‡ gi‰m «au «ßn
ca bånh ung th‹, qua viåc nghiÍn cŸu,
gi·o d¯c, yãm trÆ v‡ dŒch v¯.
Ch?ng tÙi cÛ thã gi?p «m
biåt quö vŒ l‡ ai. Xin liÍn lÂc vßi ch?ng
tÙi bvt cŸ l?c n‡o, ng‡y ho•c «Ím «ã cÛ
thÙng tin v‡ «‹Æc há trÆ.
Cancer Facts for Men,
Vietnamese version
Ung th‹ thÙng th‹©ng nhvt n÷i
nam gißi l‡ ung th‹ da, tuyân tiän
liåt, ph8i, v‡ ru?t gi‡. Hiãu biât vä
c·c bånh n‡y v‡ c·ch ngÊn ngÿa
ho•c ph·t hiån sßm cÛ thã cŸu
sanh mÂng mÏnh.
Ung ThÜ Da
Ai dÍ bÎ bŒnh này?
Ng‹©i da tr°ng, «•c biåt ng‹©i tÛc v‡ng ho•c
tÛc «’, cÛ nhiäu nguy c÷ bŒ ung th‹ da h÷n
ng‹©i m‡u da «?m, m•c d¿u ai ™ l‚u ngo‡i
n°ng «äu cÛ nhiäu nguy hiãm. Ng‹©i cÛ th‚n
nh‚n trong gia «Œnh ...
[324]
Effectiveness Matters 2(2) - Screening for prostate cancer
[62,2 KB]
From [www.york.ac.uk] Last viewed: 07.09.2006
EFFECTIVENESS
EFFECTIVENESS
Matters
Matters
NHS CENTRE FOR REVIEWS AND DISSEMINATION
Effectiveness Matters is an update on the effectiveness of health
interventions for practitioners and decision makers in the NHS. It is
produced by researchers at the NHS Centre for Reviews and
Dissemination at the University of York, based on high quality
systematic reviews of the research evidence. Effectiveness Matters is
extensively peer reviewed by subject area experts and practitioners.
The NHS Centre for Reviews and Dissemination is funded by the NHS
Executive and the Health Departments of Scotland, Wales and
Northern Ireland; a contribution to the Centre is also made by the
University of York. The views expressed in this publication are those
of the authors and not necessarily those of the NHS Executive or the
Health Departments of Scotland, Wales or Northern Ireland.
...
[325]
EHCB 8(3) - Management of colorectal cancers
[232,5 KB]
From [www.york.ac.uk] Last viewed: 07.09.2006
The Management of
Colorectal Cancers
Bulletin on the effectiveness
of health service interventions
for decision makers
Bulletin on the effectiveness
of health service interventions
for decision makers
CENTRE FOR REVIEWS AND DISSEMINATION
VOLUME 8 NUMBER 3 2004 ISSN: 0965-0288
¦ Colorectal (bowel) cancer is the
second most common cause of
cancer death in England and
Wales. Early detection and
good management result in
improved survival rates.
¦ Flexible sigmoidoscopy is the
most appropriate initial
investigation for the majority of
patients with left sided
colon symptoms.
¦ There is a clear correlation
between colonoscopy
completion rates and the
number and frequency of
examinations performed.
¦ Nurses and GPs with
appropriate training can
perform endoscopy ...
[326]
Canadian Cancer Statistics 2002
[807,2 KB]
From [www.phac-aspc.gc.ca] Last viewed: 07.09.2006
Colorectal Cancer
—
Out of Sight
NOT Out of Mind
Some people think the treatment for colorectal cancer is worse than the
disease.So they do nothing.
The fact is, when colorectal cancer
is found and treated early, your
lifestyle and your chances for contin-
ued good health will remain virtually
unchanged.
Colorectal cancer affects both men
and women. It’s the 3rd most com-
monly diagnosed cancer and the
2nd leading cause of cancer death in
Americans.
“Of the many types of cancer ,
colorectal cancer is one that is truly
preventable,” says Philip Schoenfeld,
M.D.,Assistant Professor of Gastroenterology and member of the Colorectal
Cancer Program at the University of Michigan Comprehensive Cancer Center.
“But in order to prevent it, you have to be screened, and many people
feel uncomfortable discussing that part of their body with ...
[327]
colorectal cancer brochure.qxd
[178,9 KB]
From [www.astro.org] Last viewed: 07.09.2006
RADIATION THERAPY for
COLORECTAL CANCER
Facts to Help People
Understand Treatment
Options
ABOUT
ASTRO
The American Society for Therapeutic Radiology and
Oncology is the largest radiation oncology society in the
world. The Society's mission is to advance the practice of
radiation oncology by promoting excellence in patient care,
promoting research and disseminating research results.
LEARNING ABOUT
CLINICAL TRIALS
The radiation oncology team is constantly exploring new
ways to treat colorectal cancer through studies called clinical
trials. Today's standard radiation therapy treatments are con-
stantly being refined due to the results of trials. For more
information, please contact the following organizations:
National Cancer Institute
www. cancer .gov/clinicaltrials
Radiation Therapy Oncology Group
www.rtog.org ...
[328]
CANCER INCIDENCE AND PREVALENCE IN THE MANITOBA REGIONAL HEALTH ...
[273,5 KB]
From [www.gov.mb.ca] Last viewed: 07.09.2006
CANCER INCIDENCE AND
PREVALENCE IN THE MANITOBA
REGIONAL HEALTH AUTHORITIES
Erich Kliewer
Andre Wajda
Errin Minish
April, 1998
Manitoba Health
Manitoba Cancer Treatment
Public Health Branch
and Research Foundation
Epidemiology Unit
Department of Preventive
Oncology & Epidemiology
Page 2
Page 3
i
Table of Contents
Acknowledgements
iii
Introduction
1
Definitions and Methods
1
Data
2
Tables
4
All sites (ICD-9 140-208, 230-239)
5
All sites excluding other skin (ICD-9 140-172, 174-208, 230-239)
6
Lip (ICD-9 140)
7
Pharynx (ICD-9 146-148)
8
Esophagus (ICD-9 150)
9
Stomach (ICD-9 151)
10
Colon (ICD-9 153)
11
Rectum, rectosigmoid junction, anus (ICD-9 154)
12
Liver, gallbladder, ...
[329]
Update on breast cancer incidence patterns in Marin County and the ...
[126,1 KB]
From [www.nccc.org] Last viewed: 07.09.2006
Available online: http://www.nccc.org/ResearchandTraining/studies/pdf/bcr_marin2001_0904.pdf
1
Update on breast cancer incidence patterns in Marin County and the
San Francisco Bay Area, California
Christina Clarke, Ph.D
Theresa Keegan, Ph.D
Gem Le, MHS
Sally Glaser, Ph.D
Dee West, Ph.D
Northern California Cancer Center, Union City, California
SUMMARY
Previous reports have suggested elevated rates of breast cancer in Marin County, spurring
community and scientific interest. This report provides updated data regarding breast cancer
patterns among white, non-Hispanic women in Marin County, other parts of the San Francisco
Bay Area (SFBA) and California, using the most recent information available from the California
Cancer Registry, the California Office of Vital Statistics, and the California Department of
Finance (DOF). This information updates prior reports by incorporating ...
[330]
Targeting Tumors
[152,8 KB]
From [www.ams.org] Last viewed: 07.09.2006
Targeting Tumors
Detection and treatment of cancer have progressed, but neither is as precise as
doctors would like. For example, tumors can change shape or location between
pre-operative diagnosis and treatment so that radiation is aimed at a target which
may have moved. Geometry, partial differential equations, and integer linear
programming are three areas of mathematics used to process data in real-time,
which allows doctors to inflict maximum damage to the tumor , with minimum
damage to healthy tissue.
One promising area of investigation is virotherapy : using viruses to destroy
cancerous cells. Researchers are using mathematical models to discover how to
use the viruses most beneficially.The models provide numerical outcomes for each
of the many possibilities, thereby eliminating unsuccessful approaches and identi-
fying candidates for further experimentation.Testing by simulation, which led to
...